Skip to main content
. 2021 Jun 15;12(1):2563–2575. doi: 10.1080/21655979.2021.1935525

Figure 3.

Figure 3.

KAT2B inhibited the progression of cervical cancer in vitro.

(a) The transfection efficacy was determined by qPCR. (b) Cell proliferation was measured by CCK-8. (c-i) KAT2B knockdown promoted C33A migration and invasion, KAT2B overexpression inhibited CaSki migration and invasion. (c-ii) Statistics analysis of the mean migration and invasion cell numbers as compared with the negative control (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001.